A Heterogeneous Breast Spindle Cell Tumor Revealed by Serial Imaging Follow-up: A Case Report of Sequentially Discordant Diagnoses of Desmoid-Type Fibromatosis and High-Grade Undifferentiated Sarcoma
Background: Breast soft-tissue tumors are rare and may present with overlapping imaging features, making accurate preoperative diagnosis challenging. Desmoid-Type Fibromatosis (DTF) is a locally aggressive, non-metastasizing fibroblastic tumor that can mimic breast malignancy because of its infiltrative growth pattern and irregular morphology. In contrast, high-grade undifferentiated sarcoma of the breast is an exceptionally rare but aggressive malignancy. We report a rare case of sequentially discordant diagnosis of DTF and high-grade undifferentiated sarcoma, highlighting the potential impact of intratumoral heterogeneity on radiologic-pathologic correlation. Case Presentation: A 44-year-old woman with metastatic hormone receptor-positive breast cancer underwent total mastectomy for a progressively enlarging breast mass demonstrating interval growth and chest wall involvement on serial imaging. Histopathologic examination of the mastectomy specimen revealed DTF with nuclear β-catenin positivity and a Ki-67 labeling index of approximately 30%. Three months later, a newly palpable mass developed at the operative site despite continued systemic therapy. Local excision revealed high-grade undifferentiated spindle cell sarcoma. Subsequent imaging demonstrated recurrent mass formation and persistent interval growth, and repeat excision confirmed recurrent undifferentiated sarcoma. Molecular analysis identified TP53, PIK3CA, and JAK2 variants Conclusion: This case highlights the diagnostic challenges posed by biologically heterogeneous spindle cell tumors of the breast. Atypical imaging findings and progressive growth, more aggressive than typically expected for DTF, raise the possibility of intratumoral heterogeneity, although this interpretation remains speculative without molecular confirmation. Such findings warrant careful radiologic-pathologic reassessment and serial imaging follow-up to guide management.